Rating History for Lyell Immunopharma (LYEL) by Lucid Capital Markets
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/26/2025 | Christopher Liu | New Coverage | Buy (N/A) |
20.00 (N/A) |
12.72 (14.33) |
12.66% | Details |
